Key points from article :
Tagomics, a company that develops platforms for disease diagnosis, raised £6.7 million.
Funds will be used to improve diagnosis and treatment of various diseases, including age-related diseases, rare diseases and cancers.
Its platform integrates various omics data and uses machine learning for analysis.
This approach aims to find new disease markers, advancing drug development and therapy selection for patients.
It became the first company to occupy Illumina Ventures' Labs space which provides resources for genomics startups.
Jack Kennefick, Tagomics' CEO, believes the multiomic approach will enable more accurate diagnostics.
